LAURUS LABS PVT LTD

Laurus Labs Pvt Ltd is a factory (manufacturer).

Company Introduction:

Laurus Labs Pvt Ltd is a leading research and development driven pharmaceutical company based in India. Headquartered in Hyderabad, Telangana, it specializes in the manufacturing of Active Pharmaceutical Ingredients (APIs), Finished Dosage Forms (FDFs), and provides Contract Development and Manufacturing Organization (CDMO) services to global pharmaceutical companies.

The company focuses on therapeutic areas such as antiretrovirals, oncology, anti-diabetics, and other high-growth segments. Laurus Labs operates multiple state-of-the-art manufacturing facilities that adhere to international regulatory standards, emphasizing quality, efficiency, and innovation in its production processes. It is a publicly listed company on the Indian stock exchanges and has a significant global presence, exporting its products to numerous countries worldwide.

LAURUS LABS PVT LTD (India) manufactures and sells a wide range of products primarily in the pharmaceutical sector. Their product portfolio includes:

Active Pharmaceutical Ingredients (APIs)

Examples of APIs include:

Efavirenz

Lamivudine

Tenofovir Disoproxil Fumarate

Dolutegravir

Sofosbuvir

Daclatasvir

Ledipasvir

Ritonavir

Atazanavir

Darunavir

Lopinavir

Raltegravir

Ibrutinib

Ticagrelor

Empagliflozin

Dapagliflozin

Finished Dosage Forms (Formulations)

These are complete pharmaceutical products ready for patient use, often in various therapeutic areas such as Antiretrovirals (ARVs), Oncology, Cardiovascular, and Diabetes. They produce both single-entity drugs and fixed-dose combinations.

Custom Synthesis and Contract Development and Manufacturing Organization (CDMO) Services

Laurus Labs provides custom synthesis services for drug intermediates and advanced intermediates to global pharmaceutical companies. They also offer CDMO services for both small molecules and biologics.

Biologics

Their emerging biologics division focuses on the development and manufacturing of biosimilars and recombinant products.